Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
5.03K
-
Shares change
-
0
-
Total reported value, excl. options
-
$1.96M
-
Value change
-
$0
-
Price
-
$1,051.24
Significant Holders of REGENERON PHARMACEUTICALS - COM - Call as of Q3 2024
8 filings reported holding 75886F907 - REGENERON PHARMACEUTICALS - COM - Call as of Q3 2024.
REGENERON PHARMACEUTICALS - COM - Call has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.03K shares
.
Largest 8 shareholders include BDF-GESTION (5.03K shares), JPMORGAN CHASE & CO (42.1K shares), SIMPLEX TRADING, LLC (28.9K shares), GROUP ONE TRADING LLC (13.9K shares), SG Americas Securities, LLC (10.7K shares), GARDA CAPITAL PARTNERS LP (1.2K shares), OSAIC HOLDINGS, INC. (1 shares), and JANE STREET GROUP, LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.